A. Ai Yamamoto, Ph.D.
The acclaimed Columbia neuroscientist, a leading researcher in autophagy–or protein trafficking–in Huntington’s, has turned her talents to ALS. Project ALS recruited Dr. Yamamoto and Noah Depoure, Ph.D., a quantitative biochemist at Cornell, to characterize protein aggregation in ALS. One year in to the study, Yamamoto has identified a possible strategy for augmenting protein turnover in ALS.
NextGen ALS: A Weber Family Initiative
In 2020, Cathy and Richard called Project ALS after hearing about the development of a novel antisense oligonucleotide (ASO) therapy for people living with FUS ALS. So was born NextGen ALS, a Weber family initiative in collaboration with Project ALS that is committed to raising funds for targeted research toward treatments and cures for genetic forms of ALS.
June 24, 2022
No Comments
